Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Xin Han
Professor
Laboratory Medicine
https://orcid.org/0000-0002-0197-6756
h-index
1277
Citations
15
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
1998
2023
Research activity per year
Overview
Fingerprint
Network
Research output
(28)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Xin Han is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
plasma protein Z
100%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
87%
Z protease
81%
Acute Myeloid Leukemia
76%
Tankyrases
67%
Protease Inhibitors
62%
Factor Xa
49%
Myelodysplastic Syndromes
44%
Bone Marrow
42%
Leukemia
42%
Protein-Tyrosine Kinases
40%
leukocyte-associated immunoglobulin-like receptor 1
39%
Immunoreceptor Tyrosine-Based Inhibition Motif
35%
Immunoglobulins
34%
Philadelphia Chromosome
33%
Biphenotypic Acute Leukemia
32%
Serpins
30%
Imatinib Mesylate
30%
Ehrlichiosis
29%
Dermatofibrosarcoma
28%
lipoprotein-associated coagulation inhibitor
28%
Clonal Evolution
27%
GATA2 Deficiency
27%
Lymphoid Leukemia
27%
Blast Crisis
26%
Anaplastic Large-Cell Lymphoma
26%
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
26%
Mantle-Cell Lymphoma
25%
Vulva
24%
Aspergillosis
23%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
23%
T-Cell Lymphoma
22%
Dasatinib
22%
Platelet Aggregation Inhibitors
22%
Lymphoma, Large B-Cell, Diffuse
22%
Eosinophilia
21%
Granulocyte Precursor Cells
21%
Hematopoietic Stem Cell Transplantation
21%
High-Throughput Nucleotide Sequencing
20%
Polyps
20%
Hematologic Neoplasms
20%
Fetal Blood
19%
Stem Cells
18%
Amino Acid Sequence
18%
Mutation
17%
Mesenchymal Stem Cells
17%
Therapeutics
17%
Phosphatidylethanolamines
17%
Proteins
17%
Chemistry
Protease Inhibitor
46%
Imatinib
29%
Tyrosine Kinase Inhibitor
27%
Protein
24%
Tyrosine
21%
Bosutinib
18%
Nilotinib
17%
Mutation
16%
Molecular Marker
14%
Oncogenic
13%
Complementary DNA
13%
Resistance
12%
Amino Acid Sequence
10%
Coagulation
8%
Phospholipid
7%
Haemostatic
7%
Warfarin
6%
Chemoattractant
5%
Coagulation Factor Xa
5%
Arachidonic Acid
5%
Effector
5%
Molecular Cluster
5%